Clinical Genomics Laboratory Services

A clinical genomics service provider with comprehensive genomic services to support drug discovery, translational medicine, clinical development, and precision medicine including CDx

Q2 Solutions Genomics Laboratory at a glance:

  • 4 global laboratory locations for genomics services: North Carolina, USA; Beijing, China; Edinburgh, Scotland; Singapore
  • Provided genomics services for 130 different organizations in 2021 
  • 100,000 samples isolated and sequenced annually
  • Received 200,000 samples for processing in 2021
  • 175+ assays
  • 40+ sequencing platforms in operation globally
  • 90+ bioinformaticians and software developers


Our industry-leading genomics team includes:

  • Assay development scientists
  • Bioinformatics scientists
  • Biostatisticians
  • Quality assurance and regulatory personnel 
  • Project management staff certified in PMP and Six Sigma

Q2 Solutions offers a comprehensive Immuno-Oncology Assay Portfolio

We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development:

RNA / DNA Sequencing Services

We offers a range of genomic testing services to support drug discovery, precision medicine and clinical development

Single-Cell RNA Sequencing

Accelerating research by exploring cellular heterogeneity, tracking population changes, and uncovering molecular interactions

Anatomical Pathology

Comprehensive in-house end-to-end anatomic pathology laboratory, adjunct molecular and histology services are designed to meet your clinical trial needs


Analysis solutions for insights from genomic data

Custom Assay Development

Custom laboratory assay and custom analysis design

Companion Diagnostics

Fulfilling the promise of personalized medicine

Technology Platforms

Platforms for Biomarker Solutions

Quality control (QC) metrics and regulatory standards.

Learn More

Related Thought Leaders Insights

Sense and Sensitivity – or the Pursuit of Actionable Insight in the Age of Single-Cell Biology

Speaker -  Oswaldo A Lozoya, PhD, Genomics Staff Scientist - TSAIL, Q2 Solutions   As part of the Machine Learning and Single Cell Genomics in Public Health session, Oswaldo presents insights,...

Characterization of SARS-CoV-2 using the Ion AmpliSeq SARS-CoV-2 research panel

The Thermo Fisher Ion AmpliSeq SARS-CoV-2 Research Panel is a targeted NGS solution that facilitates sequence analysis of the SARS-CoV-2 genome. This assay’s performance and the Pangolin lineage...

Automated liquid biopsy pan-cancer genomic profiling panel demonstrates utility for screening of targeted biomarkers

Advances in the analysis of circulating-free DNA (cfDNA) obtained from the plasma fraction of peripheral whole blood are facilitating minimally invasive methods to monitor health and disease. As a...